SmallCapVoice.com brought MJNA and TRTC 1st Now Take a Long Look at PIHN
Polaris International Holdings, Inc.
6860 Dallas Pkwy
Ste 600
Plano, TX 75024
Phone: 970-279-3478
procannas.net
Investment Highlights:
Maximum strength formulations available without THC. A refined CBD completely void of THC a myriad of uses in a number of specialties including pain management, sports medicine, preventative medicine and oncology, possibly increasing the effectiveness of some chemotherapy.
Much needed product in the right market at the right time. The National Cancer Institute showing that the programmed death of breast cancer cell in presence of CBD and the possibility that CBD may also enhance uptake of cytotoxic drugs into certain malignant cells is very promising.
Strong board of directors. The Company recently added Dr. Vasthi Alvarez Avila as Medical Director and to the board. Dr. Alvarez Avila graduated from Universidad De Montemorelos in Mexico. She has 8 years of medical service in Family Practice and General Surgery throughout Mexico.
PROFILE:
ProCannas offers its first-generation Cannatrol™ product line only through our trained participating physicians. Because of the purity and maximum strength of our formulations, they are best offered to patients under professional guidance. However, they will not require a formal prescription in the United States.
Daily Trades from 4/4 Click to enlarge
During the course of the extensive scientific research, conducted by noted universities and healthcare oriented organizations, a key repeatable finding, central to that research is that THC (Tetrahydrocannabinol) was not a significant contributor to the medicinal and bio-protective aspects of the plant extracts. Rather, it is the other substances (cannabinoids) that are significant active ingredients. THC is illegal in most states and is the ingredient causing one to get “high”. This finding openes the door for innovation and market success, and for ProCannas to legally develop, patent, protect and offer to the market a proprietary non-THC based Cannatrol™ formulation called Cannatrol DM, which is far less regulated by the Administration and FDA (Food and Drug Administration) as supplements, foods, and cosmetics.
ADD PIHN TO WATCHLIST FOR TRADING TOMORROW! |
|
Pink Sheets: PIHN
Market Value:
9,130,686 a/o Apr 03, 2014
Shares Outstanding:
1,086,986,400 a/o Feb 04, 2014
Float:
51,213,598 a/o Feb 04, 2014
Authorized Shares:
2,000,000,000 a/o Jan 01, 2014
Shareholders of Record:
105 a/o Feb 04, 2014
Par Value:
0.0001
Short Interest:
36,865 (100%) Mar 14, 2014
Transfer Agent:
Pacific Stock Transfer Co.
RECENT NEWS:
PIHN Hires New Medical Director to Start International Clinical Trials
Polaris International Holdings Signs Agreement With India Based Affiliates and Secures New Offices
PIHN Signs Exclusive Rights to ProCannas(R) Cannabinoid Line
KEY EXECUTIVES:
Kunimitsu Misawa
President
CEO
Treasurer
Patrick Thomas
CEO
Vasthi Alvarez Avila
Medical Director
|
